Related Experiment Videos
Advances in Huntington's disease: implications for experimental therapeutics
1Movement Disorders Center, Manhassel, NY 11030, USA. asfeigin@aol.com
Current Opinion in Neurology
|September 2, 1998
Summary
Huntington's disease is caused by a gene mutation leading to a toxic protein. Research is uncovering how this mutation causes neuronal damage, suggesting new treatments targeting mitochondria and excitotoxicity.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Huntington's disease (HD) is a neurodegenerative disorder caused by an expanded cytosine-adenosine-guanosine (CAG) trinucleotide repeat in the huntingtin gene.
- The exact mechanism by which the expanded repeat leads to progressive neuronal dysfunction and loss in HD remains incompletely understood.
Purpose of the Study:
- To explore recent advances in understanding the molecular mechanisms underlying Huntington's disease pathogenesis.
- To identify potential therapeutic strategies based on emerging insights into neuronal vulnerability and cellular dysfunction in HD.
Main Methods:
- Utilized transgenic mouse models of Huntington's disease exhibiting neuronal intranuclear inclusions.
- Investigated differential neuronal features to explain selective neuronal vulnerability in HD.
- Examined evidence for the roles of excitotoxicity and impaired mitochondrial energy production in HD.
Main Results:
- Transgenic mouse models display key pathological features of HD, including neuronal intranuclear inclusions.
- Specific neuronal populations show differential vulnerability, potentially explaining the characteristic pattern of neurodegeneration in HD.
- Evidence supports the involvement of excitotoxicity and mitochondrial dysfunction in the disease process.
Conclusions:
- Recent research provides critical insights into the pathogenic mechanisms of Huntington's disease.
- Therapeutic strategies targeting mitochondrial function and reducing excitotoxic injury show promise for treating HD.